New columnist Jolie Lizana shares her harrowing journey to a pulmonary hypertension diagnosis and finding purpose in advocacy ...

No description.

UBS analyst Ashwani Verma maintained a Buy rating on United Therapeutics (NASDAQ:UTHR) on June 30 but adjusted the price ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

Panelists discuss how the future of PAH treatment looks promising with potential for disease remission through reverse remodeling agents, emphasizing the need for continued research focus on patients ...

The pulmonary arterial hypertension market is expected to reach USD 2,080.7 million by 2025 and is expected to steadily grow at a CAGR of 2.3% to reach USD 2,612.0 million by 2035.

Researchers determined the presence of pulmonary hypertension was associated with worse outcomes for patients with polycythemia vera.

Lynn Hopkins of Ohio is happy she went with her gut and continued to explore her health issues, because it eventually led her ...

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

Body weight significantly influenced right heart function and survival in pulmonary arterial hypertension, with both extremes ...

Panelists discuss how healthcare resource utilization is primarily driven by hospitalizations, medication costs, and ...

The Cardiac Centre at Al Qassimi Hospital, operated by Emirates Health Services (EHS), has become the first facility in the ...